The Approach to the Patient with a Parapneumonic Effusion

Clinics in Chest Medicine

Volumn 27, Issue 2, 2006, Pages 253-266

  Rahman, Najib M ^a   Chapman, Stephen J ^a   Davies, Robert J O ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; FIBRINOLYTIC AGENT; GENTAMICIN; MEROPENEM; METRONIDAZOLE; STREPTOKINASE; UROKINASE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EMPYEMA; HUMAN; INCIDENCE; LUNG EMBOLISM; LUNG INFECTION; META ANALYSIS; MORBIDITY; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PLEURA EFFUSION; PLEURA FLUID; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SYSTEMATIC REVIEW; THORACOSCOPY; THORACOTOMY; THORAX DRAINAGE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOUS PLEURISY; ULTRASOUND;

COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; DRAINAGE; EMPYEMA, PLEURAL; HUMANS; PLEURAL EFFUSION; THORACIC SURGERY, VIDEO-ASSISTED; THROMBOLYTIC THERAPY;

EID: 33646559595     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.12.005     Document Type: Review

References (112)

1. MacFarlene J., Boswell T., Douglas G., et al. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56 Suppl 4 (2001) IV1-IV64
2. Light R.W., Girard W.M., Jenkinson S.G., et al. Parapneumonic effusions. Am J Med 69 4 (1980) 507-512
3. Sahn S.A. Management of complicated parapneumonic effusions. Am Rev Respir Dis 148 3 (1993) 813-817
4. Ferguson A.D., Prescott R.J., Selkon J.B., et al. The clinical course and management of thoracic empyema. QJM 89 4 (1996) 285-289
5. Sahn S.A., Taryle D.A., and Good Jr. J.T. Experimental empyema. Time course and pathogenesis of pleural fluid acidosis and low pleural fluid glucose. Am Rev Respir Dis 120 2 (1979) 355-361
6. Broaddus V.C., Hebert C.A., Vitangcol R.V., et al. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 146 4 (1992) 825-830
7. Kroegel C., and Antony V.B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 10 10 (1997) 2411-2418
8. Neff C.C., van Sonnenberg E., Lawson D.W., et al. CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage. Radiology 176 1 (1990) 195-197
9. Hamm H., and Light R.W. Parapneumonic effusion and empyema. Eur Respir J 10 5 (1997) 1150-1156
10. Sasse S.A., Jadus M.R., and Kukes G.D. Pleural fluid transforming growth factor-beta1 correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 168 6 (2003) 700-705
11. Kunz C.R., Jadus M.R., Kukes G.D., et al. Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema. Chest 126 5 (2004) 1636-1644
12. Sahn S.A., Reller L.B., Taryle D.A., et al. The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis 128 5 (1983) 811-815
13. Light R.W., MacGregor M.I., Ball Jr. W.C., et al. Diagnostic significance of pleural fluid pH and PCO2. Chest 64 5 (1973) 591-596
14. Potts D.E., Taryle D.A., and Sahn S.A. The glucose-pH relationship in parapneumonic effusions. Arch Intern Med 138 9 (1978) 1378-1380
15. Heffner J.E., Brown L.K., Barbieri C., et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 151 6 (1995) 1700-1708
16. Idell S., Girard W., Koenig K.B., et al. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 144 1 (1991) 187-194
17. Kroegel C., and Antony V.B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 10 10 (1997) 2411-2418
18. Aleman C., Alegre J., Monasterio J., et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) 105 5 (2003) 601-607
19. Idell S., Zwieb C., Kumar A., et al. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 7 4 (1992) 414-426
20. Davies C.W., Gleeson F.V., and Davies R.J. BTS guidelines for the management of pleural infection. Thorax 58 Suppl 2 (2003) ii18-ii28
21. Davies C.W., Kearney S.E., Gleeson F.V., et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 160 5 Part 1 (1999) 1682-1687
22. Givan D.C., and Eigen H. Common pleural effusions in children. Clin Chest Med 19 2 (1998) 363-371
23. Brook I., and Frazier E.H. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest 103 5 (1993) 1502-1507
24. Smith J.A., Mullerworth M.H., Westlake G.W., et al. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg 51 1 (1991) 39-42
25. Snider G.L., and Saleh S.S. Empyema of the thorax in adults: review of 105 cases. Dis Chest 54 5 (1968) 410-415
26. Yeh T.J., Hall D.P., and Ellison R.G. Empyema thoracis: a review of 110 cases. Am Rev Respir Dis 88 (1963) 785-790
27. Maskell N.A., Davies C.W., Jones E., et al. The characteristics of 300 patients participating in the MRC/BTS multicentre intra-pleural streptokinase vs. placebo trial (ISRCTN-39138989). Presented at the American Thoracic Society Meeting. Atlanta (GA), 2002
28. Chen K.Y., Hsueh P.R., Liaw Y.S., et al. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 117 6 (2000) 1685-1689
29. Maskell N.A., Davies C.W., Nunn A.J., et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352 9 (2005) 865-874
30. Bartlett J.G., and Finegold S.M. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 110 1 (1974) 56-77
31. Alfageme I., Munoz F., Pena N., et al. Empyema of the thorax in adults. Etiology, microbiologic findings, and management. Chest 103 3 (1993) 839-843
32. LeMense G.P., Strange C., and Sahn S.A. Empyema thoracis. Therapeutic management and outcome. Chest 107 6 (1995) 1532-1537
33. Poe R.H., Marin M.G., Israel R.H., et al. Utility of pleural fluid analysis in predicting tube thoracostomy/decortication in parapneumonic effusions. Chest 100 4 (1991) 963-967
34. Davies C.W., Kearney S.E., Gleeson F.V., et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 160 5 Part 1 (1999) 1682-1687
35. Colice G.L., Curtis A., Deslauriers J., et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 118 4 (2000) 1158-1171
36. Stavas J., van Sonnenberg E., Casola G., et al. Percutaneous drainage of infected and noninfected thoracic fluid collections. J Thorac Imaging 2 3 (1987) 80-87
37. Light R.W., MacGregor M.I., Luchsinger P.C., et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 77 4 (1972) 507-513
38. Jimenez C.D., Diaz G., Perez-Rodriguez E., et al. Modification of pleural fluid pH by local anesthesia. Chest 116 2 (1999) 399-402
39. Lesho E.P., and Roth B.J. Is pH paper an acceptable, low-cost alternative to the blood gas analyzer for determining pleural fluid pH?. Chest 112 5 (1997) 1291-1292
40. Maskell N.A., Gleeson F.V., Darby M., et al. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest 126 6 (2004) 2022-2024
41. Pine J.R., and Hollman J.L. Elevated pleural fluid pH in Proteus mirabilis empyema. Chest 84 1 (1983) 109-111
42. Porcel J.M., Vives M., and Esquerda A. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest 125 1 (2004) 160-164
43. Odeh M., Makhoul B., Sabo E., et al. The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion. Lung 183 1 (2005) 13-27
44. Runyon B.A., Antillon M.R., Akriviadis E.A., et al. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 28 12 (1990) 2811-2812
45. Ferrer A., Osset J., Alegre J., et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 18 4 (1999) 237-241
46. Kirsch E., Guckel C., Kaim A., et al. [The findings and value of computed tomography in pleural empyema]. Rofo 161 5 (1994) 404-411 [in German]
47. Metersky M.L. Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion?. Chest 124 3 (2003) 1129-1132
48. Eibenberger K.L., Dock W.I., Ammann M.E., et al. Quantification of pleural effusions: sonography versus radiography. Radiology 191 3 (1994) 681-684
49. Jones P.W., Moyers J.P., Rogers J.T., et al. Ultrasound-guided thoracentesis: is it a safer method?. Chest 123 2 (2003) 418-423
50. O'Moore P.V., Mueller P.R., Simeone J.F., et al. Sonographic guidance in diagnostic and therapeutic interventions in the pleural space. AJR Am J Roentgenol 149 1 (1987) 1-5
51. Yang P.C., Luh K.T., Chang D.B., et al. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol 159 1 (1992) 29-33
52. Himelman R.B., and Callen P.W. The prognostic value of loculations in parapneumonic pleural effusions. Chest 90 6 (1986) 852-856
53. Huang H.C., Chang H.Y., Chen C.W., et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest 115 3 (1999) 751-756
54. Kearney S.E., Davies C.W., Davies R.J., et al. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol 55 7 (2000) 542-547
55. Stark D.D., Federle M.P., Goodman P.C., et al. Differentiating lung abscess and empyema: radiography and computed tomography. AJR Am J Roentgenol 141 1 (1983) 163-167
56. Aquino S.L., Webb W.R., and Gushiken B.J. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 192 3 (1994) 803-808
57. Waite R.J., Carbonneau R.J., Balikian J.P., et al. Parietal pleural changes in empyema: appearances at CT. Radiology 175 1 (1990) 145-150
58. Duysinx B., Nguyen D., Louis R., et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 125 2 (2004) 489-493
59. Evans A.L., and Gleeson F.V. Radiology in pleural disease: state of the art. Respirology 9 3 (2004) 300-312
60. Neild J.E., Eykyn S.J., and Phillips I. Lung abscess and empyema. Q J Med 57 224 (1985) 875-882
61. Sahn S.A. Pleural effusions in the atypical pneumonias. Semin Respir Infect 3 4 (1988) 322-334
62. Lu P.L., Chin L.C., Peng C.F., et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 43 1 (2005) 132-139
63. Taryle D.A., Good Jr. J.T., Morgan III E.J., et al. Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother 7 2 (1981) 171-177
64. Shohet I., Yellin A., Meyerovitch J., et al. Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model. Antimicrob Agents Chemother 31 7 (1987) 982-985
65. Miller Jr. J.I. The history of surgery of empyema, thoracoplasty, Eloesser flap, and muscle flap transposition. Chest Surg Clin N Am 10 1 (2000) 45-53 [viii]
66. Peters R.M. Empyema thoracis: historical perspective. Ann Thorac Surg 48 2 (1989) 306-308
67. Sasse S., Nguyen T., Teixeira L.R., et al. The utility of daily therapeutic thoracentesis for the treatment of early empyema. Chest 116 6 (1999) 1703-1708
68. Simmers T.A., Jie C., and Sie B. Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg 47 2 (1999) 77-81
69. Storm H.K., Krasnik M., Bang K., et al. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax 47 10 (1992) 821-824
70. Shoseyov D., Bibi H., Shatzberg G., et al. Short-term course and outcome of treatments of pleural empyema in pediatric patients: repeated ultrasound-guided needle thoracocentesis vs chest tube drainage. Chest 121 3 (2002) 836-840
71. Patz Jr. E.F., Goodman P.C., and Erasmus J.J. Percutaneous drainage of pleural collections. J Thorac Imaging 13 2 (1998) 83-92
72. Ulmer J.L., Choplin R.H., and Reed J.C. Image-guided catheter drainage of the infected pleural space. J Thorac Imaging 6 4 (1991) 65-73
73. Merriam M.A., Cronan J.J., Dorfman G.S., et al. Radiographically guided percutaneous catheter drainage of pleural fluid collections. AJR Am J Roentgenol 151 6 (1988) 1113-1116
74. Silverman S.G., Mueller P.R., Saini S., et al. Thoracic empyema: management with image-guided catheter drainage. Radiology 169 1 (1988) 5-9
75. Westcott J.L. Percutaneous catheter drainage of pleural effusion and empyema. AJR Am J Roentgenol 144 6 (1985) 1189-1193
76. Cantin L., Chartrand-Lefebvre C., Lepanto L., et al. Chest tube drainage under radiological guidance for pleural effusion and pneumothorax in a tertiary care university teaching hospital: review of 51 cases. Can Respir J 12 1 (2005) 29-33
77. van Sonnenberg E., Nakamoto S.K., Mueller P.R., et al. CT- and ultrasound-guided catheter drainage of empyemas after chest-tube failure. Radiology 151 2 (1984) 349-353
78. Pothula V., and Krellenstein D.J. Early aggressive surgical management of parapneumonic empyemas. Chest 105 3 (1994) 832-836
79. Tillett W.S., and Sherry S. The effects in patients of streptococcal fibrinolysin (streptokinase) and deoxyribonuclease on fibrous, purulent and sanguinous pleural exudates. J Clin Invest 28 (2005) 173-190
80. Davies R.J., Traill Z.C., and Gleeson F.V. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 52 5 (1997) 416-421
81. Bouros D., Schiza S., Patsourakis G., et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 155 1 (1997) 291-295
82. Bouros D., Schiza S., Tzanakis N., et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 159 1 (1999) 37-42
83. Diacon A.H., Theron J., Schuurmans M.M., et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 170 1 (2004) 49-53
84. Tuncozgur B., Ustunsoy H., Sivrikoz M.C., et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 55 10 (2001) 658-660
85. Bouros D., Schiza S., Patsourakis G., et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 155 1 (1997) 291-295
86. Singh M., Mathew J.L., Chandra S., et al. Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatr 93 11 (2004) 1443-1445
87. Thomson A.H., Hull J., Kumar M.R., et al. I. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 57 4 (2002) 343-347
88. Cameron R., and Davies H.R. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2 (2004) CD002312
89. Fuchs H.J., Borowitz D.S., Christiansen D.H., et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 331 10 (1994) 637-642
90. McCoy K., Hamilton S., and Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group. Chest 110 4 (1996) 889-895
91. Light R.W., Nguyen T., Mulligan M.E., et al. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 178 1 (2000) 13-18
92. Simpson G., Roomes D., and Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 117 6 (2000) 1728-1733
93. Simpson G., Roomes D., and Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 58 4 (2003) 365-366
94. Fujiwara K., Yasumitsu T., Nakagawa K., et al. [Intrapleural streptokinase-streptodornase in the treatment of empyema and hemothorax]. Kyobu Geka 55 13 (2002) 1115-1119 [in Japanese]
95. Lindstrom S.T., and Kolbe J. Community acquired parapneumonic thoracic empyema: predictors of outcome. Respirology 4 2 (1999) 173-179
96. Pothula V., and Krellenstein D.J. Early aggressive surgical management of parapneumonic empyemas. Chest 105 3 (1994) 832-836
97. Sendt W., Forster E., and Hau T. Early thoracoscopic debridement and drainage as definite treatment for pleural empyema. Eur J Surg 161 2 (1995) 73-76
98. Ridley P.D., and Braimbridge M.V. Thoracoscopic debridement and pleural irrigation in the management of empyema thoracis. Ann Thorac Surg 51 3 (1991) 461-464
99. Striffeler H., Gugger M., Im H., et al. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg 65 2 (1998) 319-323
100. Kim B.Y., Oh B.S., Jang W.C., et al. Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema. Am J Surg 188 3 (2004) 321-324
101. Luh S.P., Chou M.C., Wang L.S., et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest 127 4 (2005) 1427-1432
102. Gates R.L., Caniano D.A., Hayes J.R., et al. Does VATS provide optimal treatment of empyema in children? A systematic review. J Pediatr Surg 39 3 (2004) 381-386
103. Waller D.A. Thoracoscopy in management of postpneumonic pleural infections. Curr Opin Pulm Med 8 4 (2002) 323-326
104. Melloni G., Carretta A., Ciriaco P., et al. Decortication for chronic parapneumonic empyema: results of a prospective study. World J Surg 28 5 (2004) 488-493
105. Anstadt M.P., Guill C.K., Ferguson E.R., et al. Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci 326 1 (2003) 9-14
106. Chen C.F., Soong W.J., Lee Y.S., et al. Thoracic empyema in children: early surgical intervention hastens recovery. Acta Paediatr Taiwan 44 2 (2003) 93-97
107. Hilliard T.N., Henderson A.J., and Langton Hewer S.C. Management of parapneumonic effusion and empyema. Arch Dis Child 88 10 (2003) 915-917
108. Kalfa N., Allal H., Montes-Tapia F., et al. Ideal timing of thoracoscopic decortication and drainage for empyema in children. Surg Endosc 18 3 (2004) 472-477
109. Wait M.A., Sharma S., Hohn J., et al. A randomized trial of empyema therapy. Chest 111 6 (1997) 1548-1551
110. Coote N. Surgical versus non-surgical management of pleural empyema. Cochrane Database Syst Rev 2 (2002) CD001956
111. Martella A.T., and Santos G.H. Decortication for chronic postpneumonic empyema. J Am Coll Surg 180 5 (1995) 573-576
112. Jimenez C.D., Diaz G., Perez-Rodriguez E., et al. Prognostic features of residual pleural thickening in parapneumonic pleural effusions. Eur Respir J 21 6 (2003) 952-955